Skip to content

Medical Devices · CAPA

Medical Device CAPA Consulting

The short answer

CAPA is the system FDA examines first in a device quality system, because it reveals whether the organization detects and fixes its own problems. We rebuild CAPA systems that resolve issues rather than close records, and we work on live investigations until the standard is repeatable in-house.

01

Why this matters

  • CAPA is a primary inspection subsystem; weaknesses there cast doubt on every other process.
  • Complaint, nonconformance, audit and service data are the inputs. When those feeds are not analysed, CAPA becomes reactive to whatever is loudest.
  • Effectiveness checks that verify completion rather than recurrence are the single most common defect we find.
02

Applicable regulations and standards

21 CFR 820.100 / QMSR
Corrective and preventive action requirements, including analysis of quality data sources.
ISO 13485 clauses 8.5.2 / 8.5.3
Corrective and preventive action within the QMS.
21 CFR 820.198
Complaint files and the interface between complaints and CAPA.
21 CFR Part 803
Medical device reporting decisions arising from complaint evaluation.
03

What our consultants actually do

  • Redesign CAPA intake, triage and risk classification so scarce investigation capacity goes to the right issues
  • Train and coach investigators in structured root cause methods on real, open records
  • Connect complaints, nonconformances, audit findings and service data into genuine trend analysis
  • Define effectiveness verification that measures recurrence, with objective criteria set at CAPA approval
  • Run backlog reduction programs with triage, batching of related records and governance
  • Independently review closed CAPAs for adequacy before an external party does
04

Across the product lifecycle

  1. 01 / DEVELOP

    Design-phase issues fed into the same problem-solving discipline.

  2. 02 / SCALE

    Nonconformance volume anticipated as production ramps.

  3. 03 / TRANSFER

    Supplier and contract manufacturer issues routed into CAPA.

  4. 04 / VALIDATE

    Validation failures investigated rather than reclassified.

  5. 05 / MANUFACTURE

    Production nonconformance trending with defined escalation.

  6. 06 / MAINTAIN

    Post-market data analysis driving preventive action.

05

Problems we are usually called about

  • Root cause recorded as human error with retraining as the action
  • Corrections documented as corrective actions, so the cause is never addressed
  • Trend thresholds set so high that nothing ever triggers
  • CAPA closure driven by due date pressure rather than evidence
  • Complaint data analysed by product line but never across the portfolio
06

Typical deliverables

  • CAPA system assessment and redesigned procedure set
  • Investigation and root cause analysis training with live coaching
  • Trend analysis methodology and threshold rationale
  • Effectiveness verification templates and criteria guidance
  • Backlog remediation plan and governance structure
07

Frequently asked

How do we reduce a large CAPA backlog without cutting corners?
Triage by risk, group records sharing a cause, close duplicates with documented rationale, and add temporary investigation capacity for the complex minority. The system redesign has to happen alongside, or the backlog returns.
What makes an effectiveness check acceptable?
Criteria defined when the action is approved, a measurement period long enough to see recurrence, and an objective data source. Confirming that a procedure was revised is not an effectiveness check.
Should every complaint open a CAPA?
No. Complaints should be evaluated and trended; CAPA should be opened based on risk and signal. A one-to-one relationship overwhelms the system and hides real trends.
08

References

Start a project

Tell us what you're working on.

Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.

CallStart a Project